+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Near Patient Care Diagnostic Market by Product Type (Cardiac Biomarker Analyzers, Glucometers, Hematology Analyzers), Technology (Biosensors, Colorimetry, Immunoassays), Application, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Near Patient Care Diagnostic Market by Product Type (Cardiac Biomarker Analyzers, Glucometers, Hematology Analyzers), Technology (Biosensors, Colorimetry, Immunoassays), Application, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
New

Near Patient Care Diagnostic Market by Product Type (Cardiac Biomarker Analyzers, Glucometers, Hematology Analyzers), Technology (Biosensors, Colorimetry, Immunoassays), Application, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129165
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Immersive Overview of Near Patient Care Diagnostics Revolutionizing Healthcare Delivery through Rapid Point-of-Need Testing and Empowering Clinicians with Real-Time Data

Near patient care diagnostics represent a pivotal evolution in healthcare delivery, moving critical testing capabilities directly into clinical settings, physician offices, and even patients’ homes. This proximity to the point of need reduces turnaround times, enables more timely interventions, and enhances the continuity of care by providing clinicians with rapid, actionable results.

As these diagnostic tools become more sophisticated, they are increasingly integrated into clinical pathways, empowering healthcare professionals to refine treatment strategies in real time. This introduction sets the stage for an exploration of key drivers, transformative shifts, and strategic insights that will both illuminate current market dynamics and provide a roadmap for stakeholders eager to accelerate innovation and improve patient outcomes.

Exploring the Pivotal Shifts Redefining Near Patient Care Diagnostics through Technological Breakthroughs and Evolving Clinical Workflows

The near patient care diagnostics landscape is undergoing seismic transformations driven by advances in assay sensitivity, miniaturization of analytical platforms, and the integration of digital health technologies. Innovations in molecular diagnostics, lateral flow assays, and multiplex immunoassays are converging to deliver unprecedented levels of accuracy and throughput at the bedside or in decentralized settings.

Simultaneously, evolving clinical workflows are demanding seamless data connectivity, prompting adoption of cloud-enabled devices and interoperability standards. These shifts are not only disrupting traditional laboratory-centric models but also catalyzing new partnerships between diagnostic manufacturers, software developers, and healthcare providers. As the ecosystem matures, stakeholders must adapt to these paradigm shifts to remain at the forefront of diagnostic excellence.

Assessing the Far-Reaching Impacts of United States Tariffs on Diagnostic Device Accessibility and Supply Chain Dynamics Across Healthcare Settings

The implementation of new United States tariff schedules on diagnostic imports has introduced complexity into supply chain planning and cost management. Manufacturers sourcing components for hematology analyzers, molecular diagnostic reagents, and rapid infectious disease tests have encountered increased procurement costs, prompting reassessments of supplier contracts and regional manufacturing footprints.

In response, some organizations have pursued nearshoring strategies, relocating critical production steps closer to key markets to mitigate tariff exposure. Others have renegotiated agreements with logistics providers to achieve greater route flexibility and cost resilience. These adjustments have not only impacted product pricing strategies but also influenced timelines for product launches and regulatory submissions.

Looking ahead, continuous monitoring of trade policy developments will remain essential. Companies that proactively engage in scenario planning and diversify their supplier networks are better positioned to navigate potential tariff escalations, ensuring uninterrupted supply of near patient care diagnostic solutions to clinicians and patients alike.

Unveiling Deep Dive Segmentation Insights across Product Types Technologies Applications End Users and Distribution Channels Shaping Market Trajectories

In evaluating product segmentation, cardiac biomarker analyzers and glucometers continue to anchor routine monitoring, while hematology analyzers and pregnancy test kits expand diagnostic breadth at the point of need. Rapid infectious disease testing, including gastrointestinal infection assays, respiratory infection tests like COVID-19, influenza, and RSV panels, and STI detection, further exemplify how granular product offerings address specific clinical scenarios.

Technological segmentation underscores the shift toward biosensors, colorimetric assays, and lateral flow immunoassays that deliver qualitative or semi-quantitative results within minutes. Concurrently, molecular diagnostics platforms are permeating near patient settings, broadening application scope to include chronic disease management and comprehensive hematology screening. End-user segmentation reveals thriving adoption in ambulatory surgical centers, clinics, diagnostic laboratories, home care programs, and hospitals, each demanding tailored workflows and support models. Distribution channels range from direct sales and distributor networks to hospital supplies, online pharmacies, and retail outlets, highlighting the importance of channel optimization to reach diverse customer segments effectively.

Analyzing Regional Dynamics and Growth Drivers across the Americas Europe Middle East Africa and Asia-Pacific Near Patient Diagnostic Landscapes

Regional dynamics in the Americas emphasize robust infrastructure investments and widespread payer coverage driving adoption of decentralized diagnostics. In the United States, integration of near patient testing into value-based care frameworks is accelerating, while Latin America exhibits growing interest in cost-effective, rapid assays to address resource constraints.

Within Europe, the Middle East, and Africa, regulatory harmonization efforts and public health initiatives foster expanding uptake of point-of-care solutions, with particular emphasis on infectious disease surveillance in emerging economies. The Asia-Pacific region, buoyed by burgeoning healthcare expenditure and digital health adoption, is rapidly emerging as a hotbed for localized manufacturing, strategic partnerships, and market entry of both global and regional players.

Illuminating Strategic Moves and Innovation Trajectories of Leading Players Driving Competition and Collaboration in Near Patient Diagnostics

Leading players are distinguished by their ability to integrate hardware, software, and service offerings into cohesive ecosystems. Strategic collaborations between diagnostics manufacturers and digital health firms are accelerating the deployment of connected devices, enabling remote monitoring and analytics-driven decision support.

Meanwhile, agile entrants are carving out niches by specializing in high-throughput lateral flow assays or modular molecular platforms that can be adapted to diverse testing needs. Mergers and acquisitions continue to reshape competitive dynamics, as established organizations acquire innovative startups to bolster their near patient diagnostics portfolios and expand global reach.

Strategic Imperatives for Industry Leaders to Capitalize on Emerging Opportunities and Navigate Challenges in Near Patient Care Diagnostics

Industry leaders should prioritize dual-track investments in digital integration and decentralized manufacturing to fortify supply chain resilience. By establishing regional production hubs and forging strategic alliances with local distributors, organizations can mitigate tariff risks and ensure consistent access to critical components.

Additionally, tailoring solutions to high-impact segments-such as respiratory infection panels for ambulatory settings or integrated chronic disease monitoring kits for home care-will unlock new revenue streams. Emphasizing user-centric design, streamlined workflows, and value-based service models will further differentiate offerings and cement long-term partnerships with healthcare providers.

Transparent Overview of Rigorous Research Methodologies and Analytical Frameworks Employed to Unearth Near Patient Care Diagnostic Market Insights

This research encompasses a comprehensive literature review of peer-reviewed journals, regulatory filings, and industry white papers to establish a robust baseline understanding of near patient care diagnostics. Primary interviews with key opinion leaders, including clinical pathologists, laboratory directors, and supply chain executives, provided qualitative insights into technology adoption and operational challenges.

Data triangulation was employed by cross-referencing findings against publicly available trade statistics, patent filings, and corporate press releases to validate trends and ascertain competitive positioning. The analytical framework integrates segmentation analysis, regional assessments, and company profiling to deliver actionable intelligence that addresses both strategic and operational priorities.

Synthesizing Core Findings and Strategic Imperatives Shaping the Future of Near Patient Care Diagnostic Innovations and Stakeholder Value

The confluence of technological innovation, evolving clinical workflows, and shifting trade policies is reshaping the near patient care diagnostic landscape. Stakeholders who adapt to these dynamics by embracing digital-enabled platforms, diversifying supply chains, and targeting high-value clinical segments will unlock sustainable growth.

Moving forward, the imperative for collaboration across manufacturers, healthcare providers, and regulatory bodies will intensify, as the collective aim remains the same: delivering rapid, accurate, and accessible diagnostic tests that improve patient outcomes and reduce system-wide costs.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Cardiac Biomarker Analyzers
    • Glucometers
    • Hematology Analyzers
    • Pregnancy Test Kits
    • Rapid Infectious Disease Tests
      • Gi Infection Tests
      • Respiratory Infection Tests
        • COVID-19 Tests
        • Influenza Tests
        • Rsv Tests
      • Sti Tests
  • Technology
    • Biosensors
    • Colorimetry
    • Immunoassays
    • Lateral Flow Assays
    • Molecular Diagnostics
  • Application
    • Cardiac Monitoring
    • Chronic Disease Monitoring
    • Hematology Screening
    • Infectious Disease Detection
    • Pregnancy Testing
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Diagnostics Laboratories
    • Home Care Users
    • Hospitals
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Hospital Supplies
    • Online Pharmacies
    • Retail Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Quidel Corporation
  • Siemens Healthineers AG
  • bioMérieux SA
  • Becton Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • Hologic Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI algorithms into handheld near patient diagnostic devices to improve accuracy and speed
5.2. Expansion of point of care molecular testing platforms for rapid infectious disease detection in clinics
5.3. Adoption of multiplex immunoassay analyzers for simultaneous biomarker detection at bedside
5.4. Growth of telehealth connected diagnostic tools enabling remote patient monitoring and virtual consultations
5.5. Regulatory clearance trends for novel near patient diagnostic technologies in the US and European markets
5.6. Emergence of wearable continuous monitoring biosensors with integrated diagnostic capabilities for chronic disease management
5.7. Shift towards cartridge based sample to answer diagnostic systems for decentralized testing in resource limited settings
5.8. Increasing partnerships between diagnostic manufacturers and software developers for data analytics integration in near patient testing
5.9. Rising demand for multiplex respiratory panels in near patient settings driven by seasonal outbreak preparedness
5.10. Innovation in smartphone enabled optical detection assays for affordable point of care diagnostics in emerging markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Near Patient Care Diagnostic Market, by Product Type
8.1. Introduction
8.2. Cardiac Biomarker Analyzers
8.3. Glucometers
8.4. Hematology Analyzers
8.5. Pregnancy Test Kits
8.6. Rapid Infectious Disease Tests
8.6.1. Gi Infection Tests
8.6.2. Respiratory Infection Tests
8.6.2.1. COVID-19 Tests
8.6.2.2. Influenza Tests
8.6.2.3. Rsv Tests
8.6.3. Sti Tests
9. Near Patient Care Diagnostic Market, by Technology
9.1. Introduction
9.2. Biosensors
9.3. Colorimetry
9.4. Immunoassays
9.5. Lateral Flow Assays
9.6. Molecular Diagnostics
10. Near Patient Care Diagnostic Market, by Application
10.1. Introduction
10.2. Cardiac Monitoring
10.3. Chronic Disease Monitoring
10.4. Hematology Screening
10.5. Infectious Disease Detection
10.6. Pregnancy Testing
11. Near Patient Care Diagnostic Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Diagnostics Laboratories
11.5. Home Care Users
11.6. Hospitals
12. Near Patient Care Diagnostic Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Hospital Supplies
12.5. Online Pharmacies
12.6. Retail Pharmacies
13. Americas Near Patient Care Diagnostic Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Near Patient Care Diagnostic Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Near Patient Care Diagnostic Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. F. Hoffmann-La Roche AG
16.3.3. Danaher Corporation
16.3.4. Quidel Corporation
16.3.5. Siemens Healthineers AG
16.3.6. bioMérieux SA
16.3.7. Becton Dickinson and Company
16.3.8. Thermo Fisher Scientific Inc.
16.3.9. Sysmex Corporation
16.3.10. Hologic Inc.
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. NEAR PATIENT CARE DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEAR PATIENT CARE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEAR PATIENT CARE DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NEAR PATIENT CARE DIAGNOSTIC MARKET: RESEARCHAI
FIGURE 26. NEAR PATIENT CARE DIAGNOSTIC MARKET: RESEARCHSTATISTICS
FIGURE 27. NEAR PATIENT CARE DIAGNOSTIC MARKET: RESEARCHCONTACTS
FIGURE 28. NEAR PATIENT CARE DIAGNOSTIC MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEAR PATIENT CARE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY CARDIAC BIOMARKER ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY CARDIAC BIOMARKER ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY GLUCOMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY GLUCOMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PREGNANCY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PREGNANCY TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY GI INFECTION TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY GI INFECTION TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COVID-19 TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COVID-19 TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY INFLUENZA TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY INFLUENZA TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RSV TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RSV TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY STI TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY STI TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY BIOSENSORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COLORIMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COLORIMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HEMATOLOGY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HEMATOLOGY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASE DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HOME CARE USERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HOME CARE USERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HOSPITAL SUPPLIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY HOSPITAL SUPPLIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 120. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 121. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 122. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 123. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. CANADA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 136. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 137. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. MEXICO NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 220. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 221. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 248. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 249. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 250. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 251. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. ITALY NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 262. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 263. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 264. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 265. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SPAIN NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RAPID INFECTIOUS DISEASE TESTS, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY RESPIRATORY INFECTION TESTS, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA NEAR PATIENT CARE DIAGNOSTIC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Near Patient Care Diagnostic Market report include:
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Quidel Corporation
  • Siemens Healthineers AG
  • bioMérieux SA
  • Becton Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • Hologic Inc.

Related Topics

Related Reports

Respiratory Infection Diagnostics Market by Technology (Immunoassay, Microbiological Culture, Molecular Diagnostics), Sample Type (Blood, Nasal Swab, Saliva), Test Mode, Infection Type, End User - Global Forecast 2025-2030 - Product Image

Respiratory Infection Diagnostics Market by Technology (Immunoassay, Microbiological Culture, Molecular Diagnostics), Sample Type (Blood, Nasal Swab, Saliva), Test Mode, Infection Type, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Critical Care Diagnostics Market by Product Type (Instruments, Reagents, Software and Services), Application (Blood Gas and Electrolyte Analyzers, Cardiac Marker Tests, Hemostasis Testing), Technology, End User, Test Mode - Global Forecast 2025-2030 - Product Image

Critical Care Diagnostics Market by Product Type (Instruments, Reagents, Software and Services), Application (Blood Gas and Electrolyte Analyzers, Cardiac Marker Tests, Hemostasis Testing), Technology, End User, Test Mode - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Rapid Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Test Kits), Technology (Immunoassay, Lateral Flow Assay, Molecular Diagnostics), End User, Application - Global Forecast 2025-2030 - Product Image

Rapid Diagnostics Market by Product Type (Instruments, Reagents & Consumables, Test Kits), Technology (Immunoassay, Lateral Flow Assay, Molecular Diagnostics), End User, Application - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Lymphedema Diagnostics Market by Application (Primary, Secondary), Distribution Channel (Offline, Online), Product Type, End User, Technology - Global Forecast 2025-2030 - Product Image

Lymphedema Diagnostics Market by Application (Primary, Secondary), Distribution Channel (Offline, Online), Product Type, End User, Technology - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.